U Lassen Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

2/2012

A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

U Lassen Research Topics

Disease

4	Neoplasms (Cancer) 01/2020 - 06/2006
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2020
1	Disease Progression 01/2020
1	Cholangiocarcinoma 05/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2012
1	Embolism (Embolus) 02/2012
1	Vomiting 06/2010
1	Myalgia 06/2010
1	Fatigue 06/2010
1	Thrombocytopenia 3 06/2010
1	Neutropenia 06/2010
1	Neoplasm Metastasis (Metastasis) 03/2003

Drug/Important Bio-Agent (IBA)

2	crenigacestatIBA 01/2020 - 01/2018
1	LigandsIBA 01/2018
1	Urokinase Plasminogen Activator ReceptorsIBA 05/2014
1	TB-403IBA 02/2012
1	Carboplatin (JM8)FDA LinkGeneric 06/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2010
1	belinostatIBA 06/2010
1	Fluorine-18IBA 03/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 05/2014 - 06/2006
1	Radiotherapy 06/2006